Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Diabetes, Retina, Business and Innovation, Health Economics and Policy, Practice Management

Shining a Light on Dry AMD - How Photobiomodulation is Helping Dry AMD Patients

sponsored by Optos

View on Demand

Monday 29th March, 7pm BST

We will present an overview of photobiomodulation (PBM) therapy and will review current research on PBM in the treatment of dry AMD.

Valeda Light Delivery System is the first approved treatment for dry AMD using photobiomodulation. Valeda is a safe and effective, multi-wavelength PBM technology designed to improve visual acuity, improve contrast sensitivity and reduce central drusen volume.

Key discussion points:

  • PBM mechanism of action
  • Clinical data on the safety and efficacy of Valeda
  • Case review and patient response to Valeda treatments

In the last couple of decades PBM therapy – a light-based treatment approach used widely for tissue repair and reducing pain and inflammation – has gained recognition among biomedical researchers and healthcare professionals. Now, LumiThera’s Valeda Light Delivery System is using a multi-wavelength PBM technology to treat ocular diseases and damage, aiming to help physicians address unmet patient needs.

Webinar Learning Objectives

  • To understand the PBM mechanism of action
  • To hear about clinical data on the safety and efficacy of Valeda
  • To be presented with several case reviews and patient response to Valeda treatments

View on Demand

Subscribe to The Ophthalmologist Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register